Patient Advocates, Manufacturers Differ on Deal

摘要

A deal to reauthorize the medical device user fee program is drawing different assessments from patient advocates and manufacturers, with the former saying it falls short in ensuring safety and the latter saying the agreement will ultimately improve healthcare. "The proposed reauthorization recommendations don't address the concerns we raised about protecting the health of patients by strengthening the FDA's capacity to ensure the safety and efficacy of devices throughout the entire life cycle," said Kate Ryan, program coordinator for National Women's Health Network, an advocacy group focused on improving women's health.